Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q2 2023 · 10-Q
Revenue$466.18K$466.18Kno prior Q2 2022 on file Net Income-$3.52M-$3.52Mno prior Q2 2022 on file EPS Diluted-$0.21-$0.21no prior Q2 2022 on file The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,551,536— Free Cash Flowderived-$3,727,230— Margins · derivedGross margin6.8%
Operating margin-749.9%
Net margin-755.7%
ended Mar 31, 2023 · filed May 12, 2023 · 42 d after period end